Cassady Schiller Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Cassady Schiller Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.27K	Buy	+15	New	+$1.38K	﹤0.01%	720

Other funds holding AXSM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cassady Schiller Wealth Management's AXSM Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Axsome Therapeutics (AXSM) in Q4 2024: 15 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #720 among its holdings.

292 funds tracked by Wall St. Rank hold AXSM as of Q4 2024.

Cassady Schiller Wealth Management held 15 shares of Axsome Therapeutics worth $1.27K as of Q4 2024.
Axsome Therapeutics was a new Cassady Schiller Wealth Management position in Q4 2024.
Axsome Therapeutics made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #720 holding.
292 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.